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THE IMMUNOGENETICS OF CHRONIC GRAFT VERSUS HOST DISEASE AND
ITS RELEVANCE FOR THE GRAFT VERSUS LEUKEMIA EFFECT
Jon J. van Rood, Eis Goulmy and Aad van Leeuwen
Department of Immunohaematology and Blood Bank,
University Hospital, Leiden, the Netherlands
INTRODUCTION
The debate whether (chronic) graft versus host disease
(cGvHD) after bone marrow transplantation reduces the chance
of leukemic relapse is certainly not definitively settled,
but the majority of those involved in bone marrow transplant-
ation including our own group feel that this is the case
(Weiden et al. 1981; Zwaan et al. 1986; Gale et al. this
Conference). Assuming this indeed to be true, an insight in
the mechanism by which cGvHD diminishes leukemic relapse
could be of importance not only for the management of
leukemia but also of other malignancies.
Good experimental evidence exists that the oecurrence
of cGvHD if donor and reeipient are MHC identical, is due to
differences for minor H(istocompatibility) or non-MHC
antigens (Goulmy et al. 1985), although viral and other
infections almost certainly play an additional role as well
(Gratama et al. 1987). During the last years we have perform-
ed a systematic study to answer the question whether donor
bone marrow derived anti-reeipient cytotoxic Τ lymphocytes
(CTLs) might oeeur during cGvHD. This turned out indeed to
be the case (Goulmy et al. 1986). Using such CTLs it was
possible to do population and (limited) family studies. The
data obtained so far are compatible with the assumption that
the determinants which are recognized are coded for by genes
which are located on chromosome 6 teleomeric from HLA-A. We
will review the available data and speculate on a mechanism
by which cGvHD could control leukemic relapse.
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MATERIALS AND ME1HODS
Penpheral blood lymphocytes
Peripheral blood lymphocytes were obtained f rom AML,
ALL, CML and AA patients In the departments of Haematology
and Pediatrics of the University Hospital in Leiden before
and after transplantation.
Cell mediated lympholysis
Cell mediated lympholysis (CML) tests were periormed as
described previously (Goulmy 1982). In brief, for the
primäry in vitro sensitizatlon, equal amounts of responder
cell s and 2000 Rad gamma irradiated stimulator cell s were
incubated for 6 days at 37°C, 5% CO in a well humidified
incubator. Thereafter, cytotoxic Τ cell llnes were grown (by
the use of specifIC irradiated feeder cells and II-2),
tested for specific cytotoxic activity and subsequently
stored in small aliquots in liquid nitrogen.
For the Performance of the CML assay, CTI s or cytotoxic I
cell lines were incubated with Cr labelled target cells
(phytohemagglutinin stimulated blast cells) at six effector
cell . target cell ratlos for 4 hrs. it 37°C. Cytotoxicity
(i.e. the amount of isotope released from Cr labelled
target cells) was determmed and c-ilculated according to the
described method (Goulmy 1982).
Protocol
As responder cells post-transplant patient's PBLs (ι e
the donor bone marrow derived PSLs) were used. As stImulator
cells, the Jiquid nitrogen stored PBLs obtamed from the
patient before transplantation were used. Becau^e all
patients studied were HLA-Α,Β,C,DR identical and MLC negat-
ive wltti their bone marrow donor, the responder cells could
only be "sensiti^td" (in vivo) against deterriinants which
were coded for by genes outside the HI A-A./DR region on
chromosome or any of the other chromosomes
RISULTS
Table 1 suromarires the results obtained in the first
famj ly te&ted (HA) . Donor and patient, a 24 year old male
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transplanted xn complete remission ίτοτα AML and now suffer-
m g from cGvHD were HIA-genotypically identical (ad)
Likewise three healthy siblmgs shared the haplotypes ac
Nevertheless, the ce]ls of the donor (obtained f rora the
donor before transplantation) and the sibling 03 tailed co
react with the CTI s taised from the patient 's PBLs obtamed
af ter bone marrow transplant ltion In other words the CTLs
recognized a determinant which was coded Lor by a gene
outside the HLA-A/DR region
rather
Mother
FAMILY HA
Haplotypes
ab
cd
Patient (pre-lransplant) ad
Donor
Sibling 03
04
05
Haplotypes
ad
ac
ac
ac
a A2,Bwb2,Cw3,DR4
b Aw24,Bw35,Cw4,DR7
c A3,Bw35,Cw4,DRl
d A2,B27,Cwl,DRl
7 lys
+91
+84
+82
_3
-16
+85
+92
TAB1Γ 1 CTI rcactivity agdinst a non-HIΑ-Λ,Η,C DK antigei
Ln i patient HA suffering f roni cGl HD and hi Ί f am 11 yine nbers
SimiJ ir CT[ s could be found m 7 out of 9 patients
suffering from cCvHD (ancludmg patient Π Α) in 1 OJt of Α
patients suffering from icute GvHD and in none of tfiL 8
pitients without CvHD
The HLA-A2 restricLed CTI s which were ob ained ftom
fc ur diffurent patienti were cestod against a pinol of
lymphocy tßo obtamed from 120 unrelatcd heilthy HI A~A^
positive donors lable 2 depict the positive and negative
re^ult«? obtamed HAI is mcluded in HA?, rhat I S HA2 is
alwiys present if HAI is po&itive HA4 and 11Λ5 are identical
m thi& panel There is a signifleant as ocution betwoen
HAI and JJA2 as weil a& HA^ -and HA5 The --ssocLaLion between
HA2 and HA4 r\ud ΗΛ5 is net significant
;•••"•'*• • 1 Ä ' t H < % f i
4 i6 / ν in Koodetdl
The segregation pattern in five family studies was
compatible wiLh the assumption that the gene or genes cochng
für HAI,2,4 and 5 were in close Imkage with HLA, although
crossovers appear to occur ab ucll (data not shown) On thc
basis of an informative crossover between HLA-A and -B, the
HA gene(s) appear(s) to be located teleomeric from ΗΓA-A
MINOR Η ANTIGEN TYPING AT THE POPULATION LEVLL
lested
Ν 64
Ν 23
Ν 13
Ν - 6
Ν 6
Ν 112
ΗΛ-Ι ΗΑ-2
pos pos
pos pos
neg pos
neg neg
neg neg
all Ηϊ Λ-Λ2 positlve
pos
HA-5
pos
neg
neg
pos
neg
TABU 2
anti-HA5
Reactivity of CTLs anti-HAl, anti-HA2, anti-HA4,
igamst a panel of 120 HLA-A2 positive mdividuals
fable 3 summarizes the typmg data for HAI, 2,4 and 5 m
64 donor-recipient pairs It is clcar that a sigmficant
maTority o( the mismatches for HA occurred m the patients
who suffered from cGvlID Furthermore the&e data Support the
notion that the great majorxty of HI Α idenfical Slblmgs are
also HA identical, wluch would be m accord with the notion
that the HA System is coded for by genes located on chromo-
some 6 ne ir HI Α
MINOR Η ANTIGIN 1YPING Ol· HI A-IDI NTICAI SIBIINCS
Donor/reclpicnt pairs
recipients wlthout GvHD
reclpients with acute GvHD
recipients with chronlc GvHD
Typing for HA-1, - 2 , -4 and -5
I d e n t i c i l non-ident3 caj
20 0
26 3
4 8
24,76
<10
TABIE J HA 1,2 4 and 5 typmg cHt-i m 64 donor-recipit-nt
pairs of a bone marrow transplantatιοη m relation Lo the
ocrurrence of cGvHD
cCVHü indGvl / / 437
DISCUSSION AND CONCLUS1ONS
The above data provide prelimmary evidence f ο τ the
existence of a locus teleomenc of HLA-A on chromos ^ me 6,
which we will call HA. Incompatibility for this locus is
associated in a very signifixant manner with the occurrence
of cGvHD and ehe presence of cytotoxic Τ lymphocytes direct-
ed against HA determinants piesent in Lhe patient but absent
in ehe donor. This I S compatible wich but not absolute proof
for the assumption that these CTLs are responsible for the
pathogenesis of cGvHD. For mstance observatlons bv Cratama
et al (1987) make it very likely that exposure Lo herpes
viruses mfluences the Initiation of GvHD as well. It can
also not yet been exeluded that the CTIs as f ar as the
pathogenesis of tht. cGvHD are only "innocent" byStanders and
that for instance activated NK cells are mamly responsible
for the lesions m cGvHD. Studies are m progress to evalu-
ate this and to determine whether the anti-HA Cfl 's leact
with epithelia! cells
Whatpver is the case , the association of the prest-nce
of anti-HA CILs with the occurrence of cGvHD and the assc-
ciation of cGvllü with a dimmi&hed leukemnc relapse after
bone mairow tranbplantatιοη raises the interesting possibi-
liLv that the anti-ΗΑ CTLs might be mvolved m the control
of the remaining leukeniic cells
En this contexL the observatlons of Van Ieeuwen et al
(1985) are of specnl intercbt. They showed that 15 cM
teltomeric f rom Hl Α-Λ on chroniosome 6 the !CA J ocus codes
for Lwu allt-les TCA-1 and 1ΓΛ-2 with genefrequencies of
respect.ivt.l> 0 45 and 0.55 In healthy mdividuals TCA
ant igen s have only been f ound on part of the Τ gdmma et 3 lb>,
but m patitntb suffertng from Τ cell malignancy oc acute ab
welJ ds chronic myelocvtic 1eukemla tiiev ive also found on
the malignant blasts themselves and a substin^ial part
(30-40%) οι all mononuclear cells (Van Ieeuwen et al 1986)
Η would be of lntoiüst to esfabli h wheLher also the
cxprcssion of the HA antigen , coded for b/ the same cliromo-
somaL reg Lon, is mereased. Ihis hypotht&is cruld tonfarmed
by quantitative cold tirget Inhibition. Obvicubly the above
JS to a large extent conjectural. Whatever tiie mswer will
bc, t\iL· question remains valid. That is it. the mechamsm
that is responsible for the dimmished lei kemic relap<se rate
in patie-nts who suffer or have suff er cd from c( VHD, an
438 / van Rood et al.
immunological one and if so, what are the effector cells and
the target determinants. In this context it would be of
interest to determine whether PBL's from patients who have
recovered from cGVHD have demonstrable anti „leukemic blast
cell activity.
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